Essays on Innovation in the Medical Device Industry- [electronic resource]
Essays on Innovation in the Medical Device Industry- [electronic resource]
- 자료유형
- 학위논문파일 국외
- 최종처리일시
- 20240214095847
- ISBN
- 9798380123396
- DDC
- 614
- 서명/저자
- Essays on Innovation in the Medical Device Industry - [electronic resource]
- 발행사항
- [S.l.]: : University of Minnesota., 2021
- 발행사항
- Ann Arbor : : ProQuest Dissertations & Theses,, 2021
- 형태사항
- 1 online resource(129 p.)
- 주기사항
- Source: Dissertations Abstracts International, Volume: 85-02, Section: B.
- 주기사항
- Advisor: Karaca-Mandic, Pinar.
- 학위논문주기
- Thesis (Ph.D.)--University of Minnesota, 2021.
- 사용제한주기
- This item must not be sold to any third party vendors.
- 초록/해제
- 요약This dissertation includes three empirical papers on the development and adoption of medical devices in the United States. Economists attribute as much as half of recent gains in life expectancy in the United States to the use of new medical technologies. When developing medical technologies, manufacturers must consider the "total product lifecycle" of devices, spanning from development costs to regulatory approval to insurer coverage and ultimately patient and physician adoption. The three chapters of this dissertation examine different stages of the total product lifecycle for medical devices.In Chapter 1, I study how medical device firms change their investments in research and develop following external shocks to production costs. Using damage to device manufacturing facilities caused by Puerto Rican hurricanes as a natural experiment, I find that increases in storm exposure cause firms to spend less on research and development and bring fewer medical devices to market. I also find that devices brought to market following storms are cited in competitor regulatory submissions no more or less often than the average medical device. This suggests that device firms do not meaningfully target more or less scientifically innovative projects at the margin when reducing investments in research and development.In Chapter 2, I describe the availability of cost-effectiveness analyses for medical devices in the United States. Cost-effectiveness analyses are not consistently used by insurers when making coverage decisions in the United States. I find that one of the barriers to using cost-effectiveness analyses is the timing of when analyses become available. Cost-effectiveness analyses are not available until several years after regulatory approval.In Chapter 3, I examine the effect of industry payments on physicians' adoption of Medtronic's Micra leadless pacemaker in fee-for-service Medicare. Leadless pacemakers have lower complication rates but a higher cost compared to traditional leaded pacemakers. I find that physicians who receive more payments from pacemaker manufacturers are more likely to adopt leadless pacemakers. However, this relationship is not robust to either physician fixed effects or an instrumental variables analysis predicting receipt of manufacturer payments as a function of distance from Medtronic headquarters.
- 일반주제명
- Public health.
- 일반주제명
- Health care management.
- 일반주제명
- Finance.
- 키워드
- Health economics
- 키워드
- Innovation
- 키워드
- Medical device
- 기타저자
- University of Minnesota Health Services Research Policy and Administration
- 기본자료저록
- Dissertations Abstracts International. 85-02B.
- 기본자료저록
- Dissertation Abstract International
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
Подробнее информация.
- Бронирование
- не существует
- моя папка
- Первый запрос зрения
- 비도서대출신청
- 야간 도서대출신청
로그인 후 이용 가능합니다.